Edgewise Therapeutics to Present at the Annual Goldman Sachs Global Healthcare Conference

Rhea-AI Summary

Edgewise Therapeutics (NASDAQ: EWTX), a muscle disease biopharmaceutical company, announced its upcoming presentation at the Annual Goldman Sachs Global Healthcare Conference. The presentation is scheduled for Monday, June 9, 2025, at 3:20 pm ET. The event will be available through a live webcast on the company's Events & Presentations page, with replay access available for a limited time after the conference. Attendees are advised to connect several minutes before the presentation starts to ensure proper connection.

News Market Reaction

+1.02%

1 alert

+1.02% News Effect

On the day this news was published, EWTX gained 1.02%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOULDER, Colo., June 3, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the Annual Goldman Sachs Global Healthcare Conference on Monday, June 9, 2025 at 3:20 pm ET. 

The presentation will be webcast live; a link for the webcast can be found on the Edgewise Events & Presentations page and will be accessible for replay, for a limited time, following the conference. It is recommended that users connect to the live webcast several minutes prior to the start to ensure a timely connection.

About Edgewise Therapeutics

Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company's deep expertise in muscle physiology is driving a new generation of novel therapeutics. Sevasemten is an orally administered first-in-class fast skeletal myosin inhibitor in late-stage clinical trials in Becker and Duchenne muscular dystrophies. EDG-7500 is a novel cardiac sarcomere modulator for the treatment of hypertrophic cardiomyopathy and other diseases of diastolic dysfunction, currently in Phase 2 clinical development. The entire team at Edgewise is dedicated to our mission: changing the lives of patients and families affected by serious muscle diseases. To learn more, go to: www.edgewisetx.com or follow us on LinkedIn, X , Facebook and Instagram.

View original content to download multimedia:https://www.prnewswire.com/news-releases/edgewise-therapeutics-to-present-at-the-annual-goldman-sachs-global-healthcare-conference-302470973.html

SOURCE Edgewise Therapeutics

FAQ

When is Edgewise Therapeutics (EWTX) presenting at the Goldman Sachs Healthcare Conference 2025?

Edgewise Therapeutics will present at the Goldman Sachs Global Healthcare Conference on Monday, June 9, 2025, at 3:20 pm ET.

How can I watch the Edgewise Therapeutics (EWTX) Goldman Sachs conference presentation?

The presentation will be available via live webcast on Edgewise's Events & Presentations page, with replay access available for a limited time after the event.

What is Edgewise Therapeutics (EWTX) main business focus?

Edgewise Therapeutics is a biopharmaceutical company focused on developing treatments for muscle diseases.

Where can I find the replay of EWTX's Goldman Sachs Healthcare Conference presentation?

The presentation replay will be accessible on Edgewise Therapeutics' Events & Presentations page for a limited time following the conference.